Vitamin C is a kinase inhibitor: Dehydroascorbic acid inhibits IκBα kinase β

Juan M. Cárcamo, Alicia Pedraza, Oriana Bórquez-Ojeda, Bing Zhang, Roberto Sanchez, David W. Golde

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Abstract

Reactive oxygen species (ROS) are key intermediates in cellular signal transduction pathways whose function may be counterbalanced by antioxidants. Acting as an antioxidant, ascorbic acid (AA) donates two electrons and becomes oxidized to dehydroascorbic acid (DHA). We discovered that DHA directly inhibits IκBα kinase β (IKKβ) and IKKα enzymatic activity in vitro, whereas AA did not have this effect. When cells were loaded with AA and induced to generate DHA by oxidative stress in cells expressing a constitutive active IKKβ, NF-κB activation was inhibited. Our results identify a dual molecular action of vitamin C in signal transduction and provide a direct linkage between the redox state of vitamin C and NF-κB signaling events. AA quenches ROS intermediates involved in the activation of NF-κB and is oxidized to DHA, which directly inhibits IKKβ and IKKα enzymatic activity. These findings define a function for vitamin C in signal transduction other than as an antioxidant and mechanistically illuminate how vitamin C down-modulates NF-κB signaling.

Original languageEnglish
Pages (from-to)6645-6652
Number of pages8
JournalMolecular and Cellular Biology
Volume24
Issue number15
DOIs
StatePublished - Aug 2004

Fingerprint

Dive into the research topics of 'Vitamin C is a kinase inhibitor: Dehydroascorbic acid inhibits IκBα kinase β'. Together they form a unique fingerprint.

Cite this